RT Journal Article
SR Electronic
T1 British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for <em>BRCA</em>1/2 variants in ovarian cancer in the United Kingdom
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 272
OP 278
DO 10.1136/ijgc-2020-002112
VO 31
IS 2
A1 Sudha Sundar
A1 Ranjit Manchanda
A1 Charlie Gourley
A1 Angela George
A1 Andrew Wallace
A1 Janos Balega
A1 Sarah Williams
A1 Yvonne Wallis
A1 Richard Edmondson
A1 Shibani Nicum
A1 Jonathan Frost
A1 Ayoma Attygalle
A1 Christina Fotopoulou
A1 Rebecca Bowen
A1 Dani Bell
A1 Ketankumar Gajjar
A1 Bruce Ramsay
A1 Nicholas J Wood
A1 Sadaf Ghaem-Maghami
A1 Tracie Miles
A1 Raji Ganesan
YR 2021
UL http://ijgc.bmj.com/content/31/2/272.abstract
AB The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.